RX Note

FEBRUARY 26, 2023

Introduction In an overview, transdermal formulations aim to deliver the drug to therapeutically active levels at the target site (either local or systemic) through skin. It has been estimated that for topical products such as creams and gels, typically only between 1% and 3% of the applied dose is bioavailable.

Community Pharmacies 52

Community Pharmacies Hospitals 52

Pharmaceutical Business Review

MAY 1, 2023

The next generation topical phosphodiesterase-4 (PDE4) inhibitor Zoryve is also indicated to treat psoriasis in the intertriginous areas. It uses a drug delivery formulation, HydroARQ Technology, which creates a non-greasy moisturising cream that easily spreads and absorbs quickly.

Adverse Reactions 52

Adverse Reactions Immunity Immunization 52

PharmaState Academy

MAY 2, 2023

The theme for the conference is “Enlightening the recent advancements in Pharmaceutical Sciences & Drug Delivery,” and it will offer a fantastic platform for attendees to participate in engaging scientific sessions, discussions, and networking opportunities.

98

98

Quality Matters

NOVEMBER 27, 2023

FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards This year has seen a flurry of activity by the U.S. Food and Drug Administration surrounding ophthalmic products. Noncompendial ophthalmic drug products should also follow the above USP 65 General Chapter. Identification threshold: 10 ppm.

Documentation 52

Documentation Packaging Dosage 52

Express Pharma

MAY 22, 2023

Carbopol is a versatile polymer having applications as a viscosity modifying agent, drug release retardant, and mucoadhesive agent in oral as well as topical drug delivery. The objective of the seminar was to increase the focus of pharma professionals on applications of its key polymer, carbopol.

Dosage 97

Dosage 97

European Pharmaceutical Review

DECEMBER 22, 2022

The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category” The term ‘mRNA’ has become commonplace globally. The success of mRNA vaccines against SARS-CoV-2 has quickly catapulted mRNA therapeutics as a disruptive, expanding drug category.

Immunity 105

Immunity Immunization Vaccines Hospitals 105

pharmaphorum

OCTOBER 12, 2022

Sustainability for Injectable Delivery Devices. Sustainability for Injectable Delivery Devices. Connected Drug Delivery Devices. Hear about new technological advances in the delivery of large volume drugs. Marc Moal, Corporate Programme Vice President, Devices and Delivery Solutions, Novo Nordisk.

Packaging 52

Packaging 52

Pharmaceutical Technology

FEBRUARY 16, 2023

The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. The Optejet microdose formulation and delivery platform use Microdose Array Print (MAP) technology for delivering 6ml-8ml of the drug.

59

59

European Pharmaceutical Review

OCTOBER 13, 2022

The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide. Traditionally, delivering protein drugs orally has been challenging.

136

136

pharmaphorum

FEBRUARY 25, 2021

Drug Delivery Devices Symposium. We have the distinct privilege of unveiling Oxford Global’s Drug Delivery Devices Symposium, taking place on the 10th of March, 2021. The post Drug Delivery Devices Symposium appeared first on. 10 March 2021 | GMT (UTC+0). Free Passes Now Available: [link]. FDDSeries21.

52

52

Express Pharma

JANUARY 21, 2024

The second edition of Pharma Live Expo & Summit, organised by the Indian Drug Manufacturers’ Association (IDMA) and Icexpo, recently concluded at the Bombay Exhibition Centre in Mumbai. The exhibition sought to showcase the advancements in the pharma sector innovations and explore the latest trends and innovations.

99

99

Pharmaceutical Business Review

MARCH 5, 2024

This platform enhances the dissolution and bioavailability of active pharmaceutical ingredients (APIs), which is crucial for topical, oral, and inhaler drug delivery.

59

59

Pharmaceutical Technology

MAY 5, 2023

The US Food and Drug Administration (FDA) has accepted Optinose’s supplemental new drug application (sNDA) for Xhance (fluticasone propionate) to treat chronic rhinosinusitis, which is now under review. The regulator has set 16 December 2023 as a prescription drug user fee act (PDUFA) target goal date.

Physician Offices 52

Physician Offices 52

Pharmaceutical Technology

APRIL 4, 2023

Gennova Biopharmaceuticals has applied for an emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its mRNA-based Omicron-specific Covid-19 booster vaccine. Dubbed GEMCOVAC-OM, the needle-free vaccine will be delivered intradermally with the PharmaJet Tropis Precision Delivery System (PDS).

Vaccines 59

Vaccines 59

pharmaphorum

NOVEMBER 17, 2021

SMi Group’s 14 th Annual Conference and Exhibition: Pre-Filled Syringes and Injectable Drug Devices 2022 – 12 th – 13 th January 2022. Sustainability for Drug Devices Focus Day – 14 th January 2022. The Future of Drug Delivery and Combination Product Device Design.

Packaging 52

Packaging 52

Pharmafile

APRIL 18, 2023

read more

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

AUGUST 2, 2022

GreenLight’s process from formulation of the drug substance and lipid nanoparticle to bulk drug product can be carried out in this facility. The RNA platform of Samsung Biologics permitted GreenLight to move from mRNA vaccine conceptualisation to the delivery of released clinical trial material in under two years.

Vaccines 104

Vaccines 104

Pharmaceutical Technology

OCTOBER 19, 2022

It has combined expertise in otology, gene therapy and inner ear drug delivery to meet the requirements of individuals with disabling hearing loss globally. Topic sponsors are not involved in the creation of editorial content. AK-OTOF is the lead product candidate of the company.

119

119

Drug Channels

JUNE 26, 2023

Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to July 28, 2023.* Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to July 28, 2023.* * Cannot be combined with other offers or used towards a current registration. Drug Channels, or any of its employees.

Biosimilars 63

Biosimilars 63

European Pharmaceutical Review

NOVEMBER 11, 2022

A paper, published in the European Journal of Pharmaceutical Sciences identified the quality assurance (QA) challenges and trends of analytical techniques in ocular drug delivery and formulation, focusing on treatments for glaucoma. seven covered testing in combination drugs. for latanoprost.”

Dosage 90

Dosage 90

Pharmaceutical Technology

MAY 24, 2023

The AMP programme is a public-private partnership between a number of biopharmaceutical and life sciences companies, the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), along with non-profit and other organisations. Topic sponsors are not involved in the creation of editorial content.

96

96

Express Pharma

MAY 16, 2023

The event featured several insightful sessions covering a wide range of topics related to the pharmaceutical export industry as well. Sandeep Modi, Joint Secretary, FPME, emphasised the role of merchant exporters in ensuring last-mile delivery of medicines to any part of the world.

98

98

European Pharmaceutical Review

OCTOBER 5, 2023

What are the key topics you plan to cover during your session at CPHI Barcelona? I firmly believe that manufacturing plays a pivotal role in this endeavour, and I will delve into topics such as production system optimisation and the standardisation of chemistry, manufacturing, and control (CMC) processes.”

Immunity 84

Immunity Immunization 84

European Pharmaceutical Review

JANUARY 29, 2024

1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way to resolution.

Drug Development 96

Drug Development Vaccines Compounding 96

pharmaphorum

NOVEMBER 1, 2022

Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more. Benefits of attending: Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities.

Clinical Pharmacology 52

Clinical Pharmacology 52

Pharmaceutical Technology

APRIL 21, 2023

Samyang Holdings Biopharm Division CEO Young-Joon Lee stated: “LG Chem has exceptional research and development expertise in innovative drug development and a number of promising new drug pipelines. This is expected to shorten the development time of new drugs and to support personalised treatments.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

MAY 15, 2023

The US Food and Drug Administration (FDA) has given orphan drug designation to SiSaf’s siRNA [a double-stranded RNA molecule that is non-coding] therapeutic, SIS-101-ADO, for the treatment of autosomal dominant osteopetrosis type 2 (ADO2), a rare and serious skeletal disorder in children.

52

52

Pharmaceutical Technology

SEPTEMBER 29, 2022

Scribe’s CasX-Editors (XE), a suite of custom engineering genome editing and delivery tools based on new foundations such as the CasX enzyme, will back Sanofi’s developing NK cell therapies pipeline for cancer. Topic sponsors are not involved in the creation of editorial content.

52

52

RX Note

JUNE 25, 2023

The information is presented in a clear and systematic outline that allows new learners to have enough background information to engage in the topic (by introducing history, specific terminology and standard treatment). The speaker should understand the topic well by reading multiple sources of information.

40

40

Pharmaceutical Technology

NOVEMBER 21, 2022

Additionally, the wide-ranging expertise of RVAC in mRNA, vaccine and drug delivery technologies, and its capabilities in research and development (R&D), biopharmaceutical manufacturing, clinical development and marketing is leveraged under the partnership. Topic sponsors are not involved in the creation of editorial content.

Vaccines 52

Vaccines 52

RX Note

OCTOBER 28, 2023

Introduction Given the potential for teratogenic effects of certain drugs, this article explores the safe use of over-the-counter medications during pregnancy. Peripartum haemorrhage, especially with complicated deliveries, due to effects on maternal platelet function. Products containing alcohol should be avoided.

Community Pharmacies 40

Community Pharmacies 40

pharmaphorum

OCTOBER 28, 2022

Nina’s role is to ensure that patients have faster access to the most promising new treatments, taxpayers get better value for money in drug expenditure and the route to funding is speeded up for responsibly priced, promising drugs. Sean Richardson , VP & General Manager UK & Ireland, Alexion. Sean Richardson.

Biosimilars 122

Biosimilars 122

Pharmaceutical Technology

AUGUST 24, 2022

According to the deal, Lacerta will oversee the discovery of the capsids, as well as their screening and validation, while Prevail will carry out the preclinical and Investigational New Drug-facilitating studies with therapeutic payloads. . Topic sponsors are not involved in the creation of editorial content.

52

52

Pharmaceutical Technology

OCTOBER 18, 2022

Moderna has entered an agreement with Gavi, the Vaccine Alliance, with regard to the delivery of Covid-19 vaccines to lower-income countries supported by the Gavi COVAX Advance Market Commitment (AMC). In August, the company sought emergency use authorization (EUA) from the US Food and Drug Administration for mRNA-1273.222, its BA.4/BA.5

Vaccines 52

Vaccines 52

Pharmaceutical Technology

APRIL 4, 2023

The company will undertake a technology transfer and feasibility study for a drug product focused on the treatment of IPF at its centre of cell and gene expertise in Milan, Italy. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

52

52

Pharmaceutical Technology

MARCH 3, 2023

“The Halle customer service team is a “one-stop-shop” for client requests when it comes to commercial drug product manufacturing,” explains Dragitsch. The batch release process itself incorporates different sub-processes to be followed by different departments.

Customer Service 52

Customer Service Documentation 52

Quality Matters

JUNE 12, 2023

Accounting for approximately 90% of prescriptions filled in the United States , generic medicines are essential to increasing patient access to important drug therapies. These similarities reflect an approved generic’s bioequivalence with the branded drug. Generic drugs are estimated to have saved the U.S.

Generic Medicine 52

Generic Medicine Dosage Prescription Filling Diabetes 52